One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen

Journal of Urology

Volumn 158, Issue 4, 1997, Pages 1431-1435

  Wang, Xuedong ^a   Brannigan, Robert E ^a   Rademaker, Alfred W ^a   Mcvary, Kevin T ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Biopsy; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0030852381     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64233-2     Document Type: Article

References (15)

1. Slawin, K. M., Ohori, M., Dillioglugil, O. and Scardino, P. T.: Screening for prostate cancer: an analysis of the early experience. CA, 45: 134, 1995.
2. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
3. Partin, A. W., Epstein, J. I., Cho, K. R., Gittelsohn, A. M. and Walsh, P. C.: Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J. Urol., 141: 341, 1989.
4. Epstein, J. I., Carmichael, M., Partin, A. W. and Walsh, P. C.: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J. Urol., 149: 1478, 1993.
5. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stanley, T. A.: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer, 66: 1225, 1990.
6. Stamey, T. A., McNeal, J. E., Freiha, F. S. and Redwine, E.: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J. Urol., 139: 1235, 1988.
7. Terris, M. K., McNeal, J. E. and Stamey, T. A.: Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J. Urol., 148: 829, 1992.
8. Stricker, H. J., Ruddock, L. J., Wan, J. and Belville, W. D.: Detection of non-palpable prostate cancer. A mathematical and laboratory model. Brit. J. Urol., 71: 43, 1993.
9. Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage (T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
10. Rosner, B.: Fundamentals of Biostatistics, 4th ed. Belmont, California: Doxbury Press, pp. 259, 299, 424 and 433, 1995.
11. Oyasu, R.: Editorial: prostate cancer. J. Urol., 157: 563, 1997.
12. Cupp, M. R., Bostwick, D. G., Myers, R. P. and Oesterling, J. E.: The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J. Urol., 153: 1543, 1995.
13. Blackwell, K. L., Bostwick, D. G., Myers, R. P., Zincke, H. and Osterling J. E.: Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. J. Urol., 151: 1565, 1994.
14. Peller, P. A., Young D. C., Marmaduke, D. P., Marsh, W. L., and Badalament, R. A.: Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer, 75: 530, 1995.
15. Humphrey, P. A., Baty, J. and Keetch, D.: Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostate carcinoma in radical prostatectomy tissues. Cancer, 75: 1842, 1995.